trial

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

NCTId NCT00145847
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 90 (actual)
Sponsored by State University of New York - Upstate Medical University
Primary completion 2008-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
90 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2003-04
Primary completion
2008-05
Eligibility
ALL · 18 Years · 69 Years

Interventions & indications

Drugs
—

Sponsors

State University of New York - Upstate Medical UniversityLead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)Collaborator

Investigators

1
Steven L Batki, MDPrincipal Investigator

Sites

4 total
Syracuse, United StatesSyracuse, United StatesSyracuse, United StatesSyracuse, United States

Facts & assertions

4 sourced
Enrollment
90
Phase
PHASE4
Primary Completion Date
2008-05
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
State University of New York - Upstate Medical University
company
collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
company
indication
Alcohol-Related Disorders
indication
Alcohol Abuse
indication
Schizophrenia
indication
investigator
Steven L Batki, MD
person